Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 14, 2003Neurology

Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1b

View Full Paper
Ask AI
Bookmark
Share

Authors

GGGavin GiovannoniQueen Mary University of London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gavin Giovannoni (2003) studied this question.

synapsesocial.com/papers/6ab33d2a6e718c783360dd5ehttps://doi.org/10.1212/01.wnl.0000082164.47224.79
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1b1999 · 135 citations
  2. 2Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis1993 · 1,972 citations
  3. 3Regression Analysis for Correlated Data1993 · 750 citations
  4. 4Final analysis of the European multicenter trial on IFNβ-1b in secondary-progressive MS2001 · 145 citations
  5. 5Randomized controlled trial of interferon-beta-1a in secondary progressive MS2001 · 459 citations